Scarica l'app Stockscreener
563.53
0.79%
-4.50
Dopo l'orario di chiusura:
563.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$568.03
Aprire:
$567.41
Volume 24 ore:
1.42M
Relative Volume:
2.48
Capitalizzazione di mercato:
$44.45B
Reddito:
$4.45B
Utile/perdita netta:
$1.10B
Rapporto P/E:
41.46
EPS:
13.591
Flusso di cassa netto:
$1.06B
1 W Prestazione:
+0.74%
1M Prestazione:
+1.78%
6M Prestazione:
-25.15%
1 anno Prestazione:
+9.31%
Intervallo 1D:
$562.89
$573.50
Intervallo di 1 settimana:
$547.90
$573.50
Portata 52W:
$504.56
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
563.53 | 44.81B | 4.45B | 1.10B | 1.06B | 13.59 |
TMO
Thermo Fisher Scientific Inc
|
492.51 | 181.06B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
182.67 | 127.84B | 24.78B | 3.68B | 5.29B | 5.1743 |
A
Agilent Technologies Inc
|
135.53 | 38.21B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
383.57 | 36.00B | 3.77B | 449.25M | 240.68M | 7.8556 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Neutral |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-31 | Aggiornamento | Stifel | Hold → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-08-05 | Reiterato | BTIG Research | Buy |
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Is Wall Street bullish or bearish on IDEXX Laboratories stock? - MSN
IDEXX Laboratories touts AI push, inVue Dx momentum at Stifel conference - MSN
IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference - inkl
A Look at IDEXX Laboratories Inc (IDXX) After 3.1% Gain -- GF Va - GuruFocus
IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test Profile - Insider Monkey
IDEXX Laboratories stock (US45168D1046): solid Q1 update keeps animal health growth story in focus - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories Expands Fecal Antigen Testing Platform With Tapeworm Detection - Moomoo
IDEXX Laboratories Inc at Stifel Jaws & Paws Conference Transcript - GuruFocus
IDEXX expands fecal testing to detect taeniid tapeworms By Investing.com - Investing.com Nigeria
Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock? - Barchart.com
IDEXX expands fecal testing to detect taeniid tapeworms - Investing.com
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection - Business Wire
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection – Company Announcement - Financial Times
11 Best Medical Technology Stocks to Buy Right Now - Insider Monkey
IDEXX Laboratories stock (US45168D1046): strong Q1 earnings keep diagnostics specialist in focus - AD HOC NEWS
IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Unveiling a 26.78% Potential Upside in the Diagnostics Arena - DirectorsTalk Interviews
IDEXX Laboratories (IDXX) Is Up 5.8% After Embedding SDMA Into Routine Catalyst CLIPs Testing - Sahm
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories stock (US45168D1046): institutional selldown and animal health growth story - AD HOC NEWS
Insider sale notice: IDEXX Labs (NASDAQ: IDXX) files Form 144 - Stock Titan
HARVEY INVESTMENT CO LLC's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
Should IDEXX’s (IDXX) SDMA-Enhanced Catalyst Panels Prompt Action From Long-Term Diagnostics Investors? - Yahoo Finance
IDEXX announces UK availability of cancer Dx panel for early detection of canine lymphoma - MSN
IDEXX Laboratories stock (US45168D1046): Q1 2026 earnings beat, guidance hike and new kidney test in - AD HOC NEWS
IDEXX Laboratories stock (US45168D1046): Q1 2026 earnings beat and updated guidance keep veterinary - AD HOC NEWS
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles - Business Wire
IDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate - Sahm
IDEXX Laboratories Inc (IDXX) Stock Up 3.2% and Still Undervalued -- GF Score: 99/100 - GuruFocus
IDEXX Laboratories stock (US45168D1046): fresh Q1 2026 earnings and guidance put diagnostics special - AD HOC NEWS
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 34% Potential Upside for Investors - DirectorsTalk Interviews
Elyxium Wealth LLC Invests $3.67 Billion in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Idexx Laboratories Shareholders Approve Governance and Meeting Reforms - The Globe and Mail
IDEXX Laboratories stock (US45167R1041): Diagnostics demand keeps investors focused - AD HOC NEWS
IDXX Technical Analysis & Stock Price Forecast - Intellectia AI
Northwestern Mutual Wealth Management Co. Increases Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories stock (US45168D1046): Q1 2025 earnings highlight growth in pet diagnostics - AD HOC NEWS
IDEXX (NASDAQ: IDXX) declassifies board, grants 25% special-meeting right - Stock Titan
Capitalizing On Growth Prospects, Irene Chang Britt Acquires IDEXX Laboratories Stock Options Worth $771 - Benzinga
Bruce L Claflin Backs Up Beliefs With A Notable Acquisition Of IDEXX Laboratories Stock Options Worth $77 - Benzinga
In A Strategic Move, Joseph L Hooley Acquires IDEXX Laboratories Stock Options Worth $771: Enhancing Valu - Benzinga
Karen Peacock At IDEXX Laboratories Exercises Options Worth $0 - Benzinga
Engaging In Insider Activity, Sam Samad At IDEXX Laboratories Exercises Options Worth $0 - Benzinga
Bessemer Group Inc. Trims Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
AustralianSuper Pty Ltd Grows Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day - 01net
IDEXX (IDXX) director Vandebroek receives RSU and option grants as compensation - Stock Titan
Director Sam Samad (NASDAQ: IDXX) receives new stock units and options grant - Stock Titan
IDEXX (IDXX) director granted stock options and deferred stock units - Stock Titan
IDEXX (IDXX) director Lawrence Kingsley awarded RSUs and stock options - Stock Titan
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):